Ionis Pharmaceuticals (IONS) Misses Q2 EPS by 13c

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/12/2026

1. SPY
2. PLTR
3. MSFT
4. TMUS
5. LBRX
6. BMY
7. MRK
8. TRAX
9. LMT
10. MIRM

Go back to Ionis Pharmaceuticals (IONS) Misses Q2 EPS by 13c

Ionis reports second quarter financial results and recent business achievements

August 9, 2022 7:00 AM EDT

Reported positive eplontersen ATTRv-PN data, on track to file NDA in H2:22

Tofersen NDA under priority review, PDUFA January 25, 2023

Completed enrollment in pelacarsen Lp(a) HORIZON and olezarsen BALANCE Phase 3 studies

On track to achieve 2022 financial guidance

Webcast today, August 9, 2022, at 11:30 a.m. Eastern Time

CARLSBAD, Calif., Aug. 9, 2022 /PRNewswire/ -- Ionis Pharmaceuticals, Inc. (Nasdaq: IONS) today reported financial results for the second quarter of 2022 and recent business achievements.

... More